I completely disagree. Leo Ehrlich has not only a

I completely disagree. Leo Ehrlich has not only a huge chunk of money but also his reputation invested in this company. How can anyone say with a straight face that he is not going to be able to put together a good board of directors, when he has thus far managed to take this company into clinical trials with very little money (compared to what such an undertaking usually costs)? Have you talked to him to discuss this or are you just speculating based on nothing? How can people be complaining about "not sticking to timelines" when we are talking about new drug development? I would much rather have a CEO with a realistic attitude that things will progress as they progress, and not set artificial timelines that will ALWAYS be missed, as virtually every biotech company has shown. I think it is much better for the company and the shareholders to continue pressing forward with research, but make no promises about when it will be completed -- because NOBODY KNOWS when it will be completed.

From the tone of this post you'd think Leo Ehrlich was somehow trying to hurt this company, and, of course, himself. If you believe that then please sell your shares and move on. I'll be happy to buy some at this level.